Antibiotic resistance poses a major threat to public health. Overuse and misuse of 12 antibiotics are generally recognised as the key factors contributing to antibiotic resistance. 13
2 genes encoding beta-lactamase and multi-drug efflux pump, together with down-regulation of 20 genes related to membrane permeability. The findings advance our understanding of the potential 21 role of NAAM chemicals in the dissemination of antibiotic resistance in microbes, and highlights 22 the need for controlling biocide applications. 23 24 25
INTRODUCTION 26
The dissemination of antibiotic resistance has become a major threat to public health. 1 Worldwide, 27 each year about 700,000 people die from antimicrobial-resistant infections, and this mortality has 28 been projected to reach 10 million per annum by 2050. 2 The spread of antibiotic resistance has 29 been attributed to the overuse and misuse of antibiotics in clinic settings, agriculture, and 30 aquaculture. 3 
31
On a global scale, non-antibiotic, antimicrobial (NAAM) chemicals are used in much larger 32 quantities than antibiotics, resulting in high residual levels of NAAM chemicals in the wider 33 environment. For example, triclosan (TCS), a common biocidal agent used in over 2,000 kinds of 34 products such as toothpaste and handwashing liquid, 4 is widely detected in aquatic environments 35 at g/L 5 to mg/L levels, 6 even up to 0.4 mg/L, 7 Evidence suggests there are potential links between 36 NAAM chemicals and antibiotic resistance. 8 For instance, mupirocin-resistant 9 and quinolone-37 resistant 10 mutants were reported to exhibit decreased susceptibility to TCS, while TCS-resistant 38 were found to have increased cross-resistance to ampicillin, ciprofloxacin 11 and erythromycin. 12 39 However, it remains unclear if NAAM chemicals such as TCS can directly induce antibiotic 40 resistance. As a preventative policy, U.S. Food and Drug Administration (USFDA) has banned the 41 addition of TCS to antibacterial soap. 13 However, the lack of unequivocal evidence for NAAM 42 chemicals inducing antibiotic resistance has prevented such a policy being adopted in other 43
countries. 44
Here, we investigated the potential of TCS to cause antibiotic resistance. Wild-type Escherichia 45 coli was exposed to TCS ranging from a sub-minimum inhibitory concentration (0.02 and 0.2 46 mg/L, which are environmentally relevant concentrations) to near lethal concentration (2 mg/L, 47 Figure. 1A). We found that after 30 days treatment, 0.2 mg/L TCS increased the mutation 48 4 frequency for multiple antibiotic resistance bacteria and the resistances were hereditable. 49 Furthermore, we demonstrated that TCS at sub-MIC could induce mutation via increased Reactive 50 Oxidative Species (ROS) generation and stress-induced mutagenesis (SIM). The subsequent 51 mutations enhanced the expressions of beta-lactamase coding gene ampC and both local and global 52 multidrug resistance regulator genes acrAB, soxS and marAB that initialized the translations of 53 beta-lactamase AmpC and multidrug efflux pumps AcrAB-TolC. Together, TCS-induced 54 mutations could induce resistance to antibiotics by increasing antibiotics efflux and antibiotic 55 degradation. 56 57
MATERIALS AND METHODS 58
Bacterial strains, triclosan, antibiotics 59 E. coli K-12 was purchased from American Type Culture Collection (ATCC 700926). Triclosan 60 was purchased from Sigma-Aldrich (USA). Antibiotics: amoxicillin (AMX), cephalexin (LEX), 61 tetracycline (TET), chloramphenicol (CHL), levofloxacin (LVX), and norfloxacin (NOR) were 62 supplied by Sigma-Aldrich (USA). Kanamycin (KAN) was supplied by Astral Scientific 63 (Australia), and ampicillin (AMP) was purchased from Gold Biotechnology (USA). 64
Culture conditions, TCS exposure, and antibiotic-resistance determination 65 E. coli K-12 stock from -80 °C was cultivated on LB agar [lysogeny broth: 5 g/L yeast extract 66 (Difco), 10 g/L NaCl and 10 g/L tryptone (Difco)] at 37 °C for 24h to isolate a single isogenic 67 strain. The isolate was grown in liquid LB for 12 h at 37 °C to reach a bacterial cell concentration 68 of 10 8 -10 9 CFU/mL. For TCS exposure experiments, 50 L of the cell suspension was inoculated 69 into 4.95 mL fresh liquid LB supplemented with different concentrations of TCS (0, 0.02, 0.2, and 70 2 mg/L, respectively) at 37 °C, shaken at 150 rpm, in triplicate. Every 24 h, 50 L of the cell 71 5 mixture was transferred to another 5 mL tube containing 4.95 mL fresh, liquid LB with respective 72 concentrations of TCS. This was repeated for 30 subculture cycles. At the end of the treatment, 73 100 L of each cell culture was plated on LB agar containing respective antibiotics at near MIC 74 (Table S1 ) at 37 °C for 48 h, and then the number of colonies were counted. The colonies grown 75 on the antibiotic-supplemented plates were considered to have resistance to the corresponding 76 antibiotic. The mutation frequency was calculated by dividing the number of antibiotic-resistant 77 colonies by the total bacterial count, which was enumerated from the LB agar without antibiotics. 78
Determination of minimum inhibitory concentrations (MICs) 79
Following 30 days 0.2 mg/L TCS exposure, and subsequent cultivation on antibiotic selection 80 plates (0.2T-AMX, 0.2T-CHL and 0.2T-TET), 5~8 antibiotic-resistant colonies were randomly 81 picked, and incubated at 37 °C for 12 h in 2 mL of liquid LB. Using the selected strains, MICs 82 were determined for eight antibiotics, respectively, including AMX, AMP, LEX, CHL, KAN, 83 LVX, NOR and TET using an initial bacterial cell concentration of 10 6 CFU/mL. Then, 15 L of 84 this cell suspension was added to each well containing 135 L of serially, 2-fold diluted antibiotics 85 in a fresh 96-well plate, followed by incubation at 37 °C for 24 h. The optical density (OD600nm) 86 was measured using a plate reader Infinite® 200 PRO (Tecan, Swiss). Each strain was tested in 87 triplicate including sterilized PBS as a blank control. Fold changes in antibiotic-MICs were also 88 calculated by dividing MICs of all treated mutants by the MIC of the wild-type E. coli ( Figure 1C) . 89
Hereditary stability test 90
Antibiotic-resistant mutants (0.2T-AMX, 0.2T-CHL and 0.2T-TET) used for MIC profiling were 91 cultivated in 5 mL liquid LB without antibiotics or TCS at 37 °C and 150 rpm. After 24 h, 1% of 92 each liquid cell culture was transferred to fresh 5 mL treatment-free liquid LB and incubated under 93 the same conditions. After five cycles, the MICs of eight antibiotics were tested respectively using 94 6 the same method described previously, and the fold changes in MICs were determined. Each 95 sample was tested in triplicate. MIC fold changes were determined for the cell cultures at day 0 96 and day 5 of incubation ( Figure 1D , E and F). 97
Live and dead cells percentages 98
The inhibitory effect of TCS on E. coli K-12 were investigated by staining with BacLight TM 99 Bacterial Viability Kit (Invitrogen, USA). The LIVE/DEAD cell ratio of TCS-treated (0, 0.02, 0.2, 100 and 2 mg/L TCS for 2 h) E. coli was then dual stained with propidium iodide (final concentration: 101 30 M) and SYTO 9 (final concentration: 5 M) in the dark at room temperature for 30 mins. The 102 fluorescence was quantified by applying 500 L (10 6 CFU/mL) of the stained samples to a 103 CYTOFLEX flow cytometer (BD Biosciences, USA) with 488 nm excitation, and emissions were 104 measured above 630 nm for red (PI) fluorescence and at 520 nm for green (SYTO 9) fluorescence. 105
Untreated and heat-treated (2 h at 80 °C) cells were used as controls for intact and damaged cells, 106 respectively. 107
Detection of Reactive Oxygen Species (ROS) 108
To explore whether oxidative stress plays a role in promoting TCS-induced mutation, intracellular 109 ROS formation was determined using the dye 2',7'-dichlorofluorescein diacetate (DCF-DA, 110
Abcam, UK), which can be oxidized by ROS into fluorescent compound, 2', 7'-111 dichlorofluorescein (DCF), and measured with an Accuri C6 cytometer (BD Biosciences, USA). 112
Briefly, bacterial cell suspensions (approximately 10 6 -10 7 CFU/mL) were incubated with DCF-113 DA (at a final concentration of 20 M) for 30 min at 37 °C, shaken at 100 rpm in the dark. The 114 bacterial cells were then directly treated with TCS (0.02, 0.2, and 2 mg/L) for 2 h at 37 °C, shaken 115 at 100 rpm in the dark. A tert-butyl hydrogen peroxide (TBHP)-treated sample (50 M) was used 116 as a positive control, and three non-TCS-treated samples as negative controls. The samples were 7 then scanned by an Accuri C6 cytometer, and the DCF fluorescence (excitation at 488 nm/emission 118 at 525 nm) was measured to deduce the ROS production level ( Figure 1H ). The relative ROS 119 production level after dosage with 0.2 mg/L TCS for 2 h was determined for wild-type E. coli and 120 0.2T-AMX-, 0.2T-CHL-and 0.2T-TET-resistant strains which had been originally incubated with 121 0.2 mg/L TCS, 30 days ( Figure 1I ). 122
DNA extraction, Illumina sequencing and data processing 123
MIC-profiled colonies from 0.2T-AMX-, 0.2T-CHL-and 0.2T-TET-resistant strains, and 124 untreated E. coli K-12 were cultured in duplicate in 10 mL liquid LB at 37 °C for 16 h (shaken at 125 150 rpm) to reach 10 7~1 0 8 CFU/mL. Bacteria were then collected by 10 min centrifugation at 8000 126 × g, and genomic DNA was extracted using FastDNA™ SPIN Kit for Soil (MP, USA) following 127 the manufacturer's instructions. The NexteraXT DNA Sample preparation kit (Illumina, USA) was 128 used to prepare a whole-genome shotgun library which was sequenced by AGRF (Brisbane, 129 Australia) using a MiSeq instrument (Illumina, USA) with 150 bp paired-end sequencing, to a 130 coverage of over 100-fold. A reference genome for E. coli strain K-12 was obtained from Genbank 131 (Accession NC000913.3). The Illumina paired-end raw data was trimmed by Trimmomatic 132 version 0.36 14 to remove adapter and other illumine-specific sequences from the reads. After this, 133 only properly paired reads were kept for further downstream analysis. These high read-depth data 134 sets were aligned back to reference to study small variants e.g. Single nucleotide polymorphism 135 (SNP), short indel (insertion or deletion), using BreSeq version 0.29.0. 15 The allele frequency 136 information was then extracted, and highly divergent loci were subjected to further analysis. 137
Throughout the process, data visualization tools such as BRIG 16 and Mauve 17 were utilized for 138 comprehensive comparisons and graphical plots. 139
RNA extraction, genome-wide RNA sequencing and transcriptomic analysis 140 8 MIC-profiled 0.2T-AMX-, 0.2T-CHL-and 0.2T-TET-resistant mutants as well as the wild-type 141 strain E. coli K-12 were cultured in triplicate in 10 mL liquid LB with 0.2 mg/L TCS at 37 °C for 142 8 h, shaken at 150 rpm. Bacterial cells were then collected by 10 min centrifugation at 8000 × g. 143
Total RNA was extracted from the mutants using the QIAGEN miRNeasy Mini Kit (QIAGEN, used to treat the raw sequence reads to trim the 3'-end residual primers and adaptors, following 150 the removal of the ambiguous characters in the reads. Then, the sequence reads consisting of at 151 least 85% bases were progressively trimmed at the 3'-ends until a quality value ≥ 20 were kept. 152
Downstream analyses were performed using the generated clean reads of no shorter than 75 bp. 153
The clean reads of each sequenced strains were aligned to the E. coli reference genome 154 (NC_000913) using SeqAlto (version 0.5). The strand-specific coverage for each gene was 155 calculated using Cufflinks (version 2.2.1), and to evaluate the differential t in triplicate bacterial 156 were assessed using Independent-samples t-test. A value of p < 0.05 was considered significant, 172 and a value of p < 0.01 was considered very significant. 173
Data availability 174
All DNA sequencing data have been deposited with the National Center for Biotechnology 175 Information (NCBI), and this is accessible through the SRA series (accession no. SRP124796). 176
All RNA sequencing data have been deposited to the NCBI Gene Expression Omnibus, and this 177 is accessible through the GEO series (accession no. GSE107048). 178 179
RESULTS AND DISCUSSION 180
TCS treatment induces heritable multi-antibiotic resistance 181
We exposed wild-type E. coli to TCS with different concentrations (0, 0.02, 0.2 and 2 mg/L). 182
Enumeration of antibiotic-resistant strains was carried out every 5 days by plating on LB agar 183 supplemented with antibiotics (Table S1 ). The number of resistant colonies grown on plates 184 containing different antibiotics was divided with total bacteria number to obtain the "mutation 185 frequency". The spontaneous mutation frequencies against eight types of antibiotics were 186 10 established using the wide-type strain (non TCS−treated), which varied from 10 −7 to 10 −8 for 187 different antibiotics. Then the mutation frequencies of TCS treated samples were compared with 188 control and the increase of mutation frequency were calculated by the normalization to the 189 spontaneous mutation frequency ( Figure 1B contrast, exposure to TCS at 0.02 and 2 mg/L did not lead to any significant increase in antibiotic-195 resistant mutants compared to the control without exposure to TCS ( Figure 1B and Table S2 ). Figure 1A) . The 0.2T-AMX mutants expressed 6.7-fold increased MIC against the three beta-202 lactam antibiotics, ampicillin (AMP), cephalexin (LEX) and AMX. The 0.2T-CHL and 0.2T-TET 203 mutants also showed increased MICs to multiple antibiotics of different categories ( Figure 1C 
TCS enhances generation of reactive oxygen species (ROS) 211
Previously, antibiotics were found to epigenetically generate antibiotic-resistant mutations via 212 ROS stress response systems that damage DNA and the subsequent DNA repair system. 19 Thus, 213 we tested ROS generation and cell viability using flow cytometry, to verify whether TCS can 214 induce oxidative stress in E. coli. We found that exposure to TCS at 0.2 and 2 mg/L for 2 h induced 215 inhibitory effects on E. coli growth, the total cell concentration reduced from 8.86 × 10 6 ± 7.79 × 216 10 5 cell/mL (0 mg/L TCS) to 8.17 × 10 5 ± 3.03 × 10 4 cell/mL (0.2 mg/L TCS) and 5.06 × 10 5 ± 217 2.60 × 10 4 cell/mL (2 mg TCS) ( Figure 1G ). Meanwhile, TCS exposure increased dead cell number 218 from 1.33 × 10 3 ± 4.71 × 10 2 cell/mL (0 mg/L TCS) to 1.66 × 10 3 ± 4.71 × 10 2 cell/mL (0.2 mg/L 219 TCS) and 5.00 × 10 3 ± 8.16 × 10 2 cell/mL (2 mg TCS). More importantly, both 0.2 and 2 mg/L 220 TCS treatments significantly increased generation of ROS for 5.00 ± 1.24 folds and 9.37 ± 0.78 221 folds, respectively ( Figure 1H ). In contrast, TCS treatment at 0.02 mg/L did not trigger significant 222 ROS generation ( Figure 1H ) or cell inhibition ( Figure 1G ), which is consistent with a previous 223 report(10) that TCS at 0.03 mg/L did not induce antibiotic resistance. Noticeably, although TCS 224 dosage of 2 mg/L increased the ROS production, it did not increase mutation frequency (Figure  225 1B), likely because this near-MIC dosage of TCS reduced the frequency of accumulating 226 mutations by decreasing the cell proliferation rate. These results indicate that there might be a 227 threshold TCS concentration for the generation of antibiotic resistance. Moreover, TCS-induced 228 mutants generated less ROS compared to wild-type E. coli (Figure 1I ), suggesting mutants have 229 developed resistance to TCS-induced oxidative stress. 230
231

TCS triggers genetic mutations 232 12
To reveal the genetic changes involved in TCS-induced antibiotic resistance, we conducted 233 genome-wide DNA sequencing on three types (0.2T-AMX, 0.2T-CHL and 0.2T-TET) of 234 replicated TCS-induced mutants (n = 6) and wild-type E. coli (n = 2) ( Figure 2 ). Sequencing of 6 235 antibiotic-resistant mutants generated after exposure to TCS at 0.2 mg/L revealed 14 genetic 236 changes in 11 genes and 9 mutations in intergenic spacers compared with the untreated E. coli 237 ( Figure 2 and Tables S3). All sequenced mutants displayed the +A insertion in the insB−1 gene as 238 well as substitution mutations in the fabI gene. TCS inhibits bacterial fatty acid synthesis by 239 binding enoyl reductase FabI which encoded by fabI gene, 20 therefore missense mutation in the 240 fabI gene could reduce TCS efficacy by altering the structure of the target FabI protein. 21 In 241 addition to these shared mutations, some strain-specific mutations were also identified. For 242 example, the substitution mutations of acrR (L65R), citC (A346T) and soxR (R20S) genes were 243 only identified in the 0.2T−CHL strains. For the 0.2T−TET strain, a Δ1 bp frameshift in insl−1 244 gene and a substitution mutation in marR gene (T72P) were unique compared to other strains. 245
Lastly, the 0.2T−AMX strain were detected with genetic changes include the substitution 246 mutations in aaeB (V311G) and rpoD genes (D445G), an insertion in frdD gene (345/360 nt) as 247 well as an insertion in intergenic spacer between rrlG and rrfG genes ( Figure 2C) . 248
249
TCS exposure regulates gene expression levels 250
In parallel, molecular mechanisms responsible for TCS-induced antibiotic resistance were 251 determined by transcriptional analysis. Whole genome Illumina RNA sequencing was conducted 252 on three types of mutants (n = 9) and wild-type E. coli (n = 3) in response to 0.2 mg/L TCS 253 exposure for 8 h. Compared with non-treated wild-type E. coli (n = 3), acute exposure to TCS (t = 254 8 h) lead to representative changes in transcription among mutants and wild-type E. coli ( Figure  255 13 S1A and B). For wild-type E. coli, acute TCS exposure enhanced the expression of SIM network 256 genes, such as umuC and yfjY that encode for DNA repair, efflux system-coding genes acrE, mdtE, 257 acrF, mdtB, mdtC and yddA, and metallo-beta-lactamase superfamily coding gene yjcS (p < 0.05, 258 Figure 3A , Tables S5, S6 and S7 ). In contrast, the expression of ygiW, soxS and yhcN genes that 259 encode cellular antioxidants as well as membrane porin-encoding gene ompX were down-regulated 260 ( Figure 3A and Table S6 S7 and S8). These results suggest that at 0.2 mg/L TCS applies oxidative 261 stress to E. coli while decreasing the expression of cellular antioxidant-encoding genes, which 262 could then trigger the SIM response to DNA damage. 263
264
In TCS-induced mutants, genes encoding cellular antioxidants significantly increased (p < 0.05) 265 expression levels when exposed to TCS, compared to non TCS-treated wild-type (e.g., sodA and 266 yggX, Table S8 ), and this may lead to reduced ROS generation compared to the untreated E. coli 267 ( Figure 1I) . In contrast, the expression levels of SIM-network gene argD and membrane porin-268 encoding gene phoE were significantly decreased when treated with 0.2 mg/L TCS ( Figure 3A leading to the increased tolerance to beta-lactam antibiotics 24 ( Figure 1C, 2C, 3A and Table S7 ). 278
14
In 0.2T-CHL strains, mutation in the acrR gene might have caused impaired function of acrAB 279
repressor AcrR, 25 resulting in increased transcription of the AcrAB multidrug efflux pump-coding 280 genes acrAB. 26 Additionally, mutation in the soxR gene may have increased the expression of 281 soxS, 27 resulting in an increase in efflux by up-regulating the acrAB. 28 Therefore, overexpressed 282
AcrAB multidrug efflux pump is likely to contribute to multiple antibiotic resistance 29 (Figure 1C Every 24 h, 1% of TCS-treated E. coli culture was transferred into a fresh medium containing the 318 same concentration of TCS. After 30 cycles, antibiotic-resistant strains were isolated by plating 319 on LB agar supplemented with eight antibiotics, respectively (supplementary Table 1 ). Resistant 320 strains isolated in this way were randomly selected to profile the MIC of multiple antibiotics (n = 321 
